Brief: Daré Bioscience Announces Positive Pharmacokinetic (Pk) Results From The Dare-Hrt1 Phase 1 / 2 Study That Support The Potential Of Dare-Hrt1 As An Effective Hormone Therapy For Both Vasomotor And Vaginal Symptoms Of Menopause

Dare Bioscience

09/01/2023 13:30

Dare Bioscience Inc  DARE.O :
    * DARÉ BIOSCIENCE ANNOUNCES POSITIVE PHARMACOKINETIC (PK)
RESULTS
FROM THE DARE-HRT1 PHASE 1 / 2 STUDY THAT SUPPORT THE POTENTIAL
OF DARE-HRT1 AS AN EFFECTIVE HORMONE THERAPY FOR BOTH VASOMOTOR
AND VAGINAL SYMPTOMS OF MENOPAUSE

Source text for Eikon:  ID:nGNX5MC1Dm 
Further company coverage:  DARE.O